Bruton's tyrosine kinase inhibitors (Btkis): review of Preclinical studies and evaluation of clinical trials

D Rozkiewicz, JM Hermanowicz, I Kwiatkowska… - Molecules, 2023 - mdpi.com
In the last few decades, there has been a growing interest in Bruton's tyrosine kinase (BTK)
and the compounds that target it. BTK is a downstream mediator of the B-cell receptor (BCR) …

Waldenström macroglobulinemia: a review of pathogenesis, current treatment, and future prospects

B Ghafoor, SS Masthan, M Hameed, HH Akhtar… - Annals of …, 2024 - Springer
Waldenström macroglobulinemia (WM) is a chronic B-cell lymphoproliferative disorder
characterized by lymphoplasmacytic cell overgrowth in the bone marrow and increased …

Clinicopathological characteristics and prognosis in patients with monoclonal gammopathy and renal damage in central China: a multicenter retrospective cohort …

H He, Z Wang, J Xu, Y Liu, Y Shao, Y Hou, J Gu… - Scientific Reports, 2024 - nature.com
Renal involvement is common in monoclonal gammopathy (MG); however, the same patient
may have both MG and non-paraprotein-associated renal damage. Accordingly …

The role of therapeutic plasma exchange in plasma cell disorders

D Dima, J Khouri - Annals of Hematology, 2024 - Springer
Therapeutic plasma exchange (TPE) is an extracorporeal technique where patient's plasma
containing pathogenic substances is separated and removed from the whole blood, while …

Schnitzler Syndrome: Insights into Its Pathogenesis, Clinical Manifestations, and Current Management

A Braud, D Lipsker - Biomolecules, 2024 - mdpi.com
Schnitzler syndrome is a rare disorder characterized by a chronic urticarial rash associated
with immunoglobulin M (IgM) monoclonal gammopathy. Schnitzler syndrome shares strong …

[HTML][HTML] Waldenström Macroglobulinemia-A State-of-the-Art Review: Part 1: Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, risk …

M Bibas, S Sarosiek, JJ Castillo - Mediterranean Journal of …, 2024 - ncbi.nlm.nih.gov
Waldenström macroglobulinemia (WM) is an infrequent variant of lymphoma, classified as a
B-cell malignancy identified by the presence of IgM paraprotein, infiltration of clonal, small …

In-depth molecular analysis of lymphomas with lymphoplasmacytic differentiation may provide more precise diagnosis and rational treatment allocation

A Brunner, GC Thalhammer-Thurner… - Annals of …, 2024 - Springer
We performed a molecular analysis of formalin-fixed paraffin embedded and decalcified
bone marrow trephine biopsies of 41 patients with a B-cell disorder with lymphoplasmacytic …

Serum CXCL13 level is related to treatment response and predicts disease prognosis in Waldenström macroglobulinemia

J Chen, M Jia, H Cai, Z Li, J Li, D Zhou, X Cao - Annals of Hematology, 2024 - Springer
Waldenström macroglobulinemia (WM) is a type of B-cell lymphoma that produces IgM. Our
study aimed to investigate the role of CXCL13, a chemokine essential for B lymphocytes, in …

[HTML][HTML] Optical coherence tomography angiography features in Waldenström macroglobulinemia patients without Hyperviscosity syndrome: A pilot prospective study

G Cennamo, M Rinaldi, A Severino, L De Fazio… - Photodiagnosis and …, 2024 - Elsevier
Purpose To evaluate the retinal vessel density (VD) with optical coherence tomography
angiography (OCTA) in asymptomatic patients affected by Waldenström macroglobulinemia …

Lymphoplasmacytic lymphoma and multiple myeloma coexisting in the same patient: a case series and literature review

G Itchaki, O Jarhovsky, JJ Castillo, H Hassan… - Leukemia & …, 2024 - Taylor & Francis
The simultaneous occurrence of Waldenström macroglobulinemia and multiple myeloma in
the same patient has been published as case reports. Patients with Waldenström …